Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...
Obsidian Energy ( TSE:OBE ) Third Quarter 2024 Results Key Financial Results Revenue: CA$197.8m (up 9.8% from 3Q 2023... Higher third quarter funds flow from operations of $124.7 million ($1.64 ...